Damian Pharma AG
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| DP13 - A Phase II Study in Patients With Primary Aldosteronism (NCT04007406) | Damian Pharma AG | 2019-11-21 |
Track Damian Pharma AG automatically
Every clearance here is in the API, with alerts when new ones post.